Dr Martens plc (DOCS) ORD GBP0.01
Share news, reports & tips
13 April 2022 09:36
(Sharecast News) - Analysts at Barclays cut their target price on iconic bootmaker Dr Martens from 480.0p to 360.0p on Wednesday but said it still sees as much as 50% upside to the stock's current price.
27 January 2022 07:51
(Sharecast News) - Shares in bootmaker Dr Martens slumped early on Thursday despite it posting third-quarter group revenues that were in line with internal expectations amid slowing sales growth and a...
6 January 2022 08:08
(Sharecast News) - Dr Martens tumbled on Thursday after private equity firm Permira sold 65m shares in the iconic bootmaker in a placing, which made up around 15% of its holdings.
9 December 2021 07:23
(Sharecast News) - Iconic UK footwear brand Dr Martens posted a 46% rise in interim profits, driven by a recovery in physical stores sales as they reopened from Covid curbs, but warned that shipping delays...
1 December 2021 08:23
(Sharecast News) - Barclays upgraded Dr Martens to 'overweight' from 'equalweight' on Wednesday, keeping the price target at 480p, as it argued that the iconic footwear company has an...
29 July 2021 08:29
(Sharecast News) - Iconic boot maker Dr Martens said on Thursday that revenues jumped in the first quarter, with trading "slightly" ahead of its expectations and growth across all regions.
13 July 2021 12:58
(Sharecast News) - Dr Martens: Goldman Sachs upgrades to buy with a target price of 535p.
13 July 2021 09:43
(Sharecast News) - Goldman Sachs upped Dr Martens to 'buy' from 'neutral' on Tuesday, hiking the price target to 535p from 490p.
21 June 2021 15:57
(Sharecast News) - Dr Martens revealed on Monday that non-executive director Robyn Perriss had acquired 20,000 ordinary shares in the FTSE 250-listed boot-maker.
17 June 2021 07:36
(Sharecast News) - In its first results as a listed company, Dr Martens reported a jump in full-year revenue and earnings on Thursday thanks to solid online sales, as it reiterated its medium-term guidance.
18 April 2021 12:04
(Sharecast News) - The Sunday Times's Sam Chambers advised readers to "avoid" shares of Dr Martens, cautioning of the potential long-term pitfalls of its current focus on profitability.
11 March 2021 10:36
(Sharecast News) - Barclays and Royal Bank of Canada were both positive about Dr Martens as they started coverage but Barclays was more cautious about the boot maker's valuation.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.